G+FLAS LIFE SCIENCES
4Patents
4Active
4Granted
44Portfolio score
Filing activity: Dec 21, 2018 → Feb 9, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11293019B2 | Chimeric genome engineering molecules and methods | Chemistry; Metallurgy | 2 | Active |
| US11865164B2 | Pharmaceutical composition for treating cancer, containing guide RNA and endonuclease as active ingredients | Human Necessities | 0 | Active |
| US11491208B2 | Sequence-specific in vivo cell targeting | Chemistry; Metallurgy | 0 | Active |
| US11434478B2 | Compositions and methods for genome engineering with Cas12a proteins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.